business
AbbVie Touts Record Sales and Pipeline Momentum at Annual Meeting
Key takeaways
- Abb Vie Touts Record Sales and Pipeline Momentum at Annual Meeting Market Beat Sat, May 9, 2026 at 9:07 PM GMT+7 6 min read ABBV Abb Vie logo Key Points Interested in Abb Vie Inc.?
- Abb Vie reported record 2025 results, with total net revenues of $61.2 billion and adjusted EPS of $10.54, both ahead of expectations.
- The company emphasized long-term pipeline and business-development momentum, saying it has nearly 90 clinical programs in development and invested more than $5 billion in external innovation last year.
Abb Vie Touts Record Sales and Pipeline Momentum at Annual Meeting Market Beat Sat, May 9, 2026 at 9:07 PM GMT+7 6 min read ABBV Abb Vie logo Key Points Interested in Abb Vie Inc.? Here are five stocks we like better.
Abb Vie reported record 2025 results, with total net revenues of $61.2 billion and adjusted EPS of $10.54, both ahead of expectations. Management said sales grew 8.6% even as Humira continued to face erosion.
The company emphasized long-term pipeline and business-development momentum, saying it has nearly 90 clinical programs in development and invested more than $5 billion in external innovation last year. Priority areas include immunology, neuroscience, oncology and obesity.
Article preview — originally published by Yahoo Finance. Full story at the source.
Read full story on Yahoo Finance →
More top stories
Also covered by
Investing.com
Cascades shareholders elect 11 directors at annual meeting
Investing.com
Critical Mineral Resources schedules June 3 annual meeting
Investing.com
NVR shareholders re-elect directors and vote on proposals at annual meeting
Investing.com
Gibraltar Industries reports results of annual shareholder meeting
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop